0001062993-20-004521.txt : 20200916 0001062993-20-004521.hdr.sgml : 20200916 20200916161914 ACCESSION NUMBER: 0001062993-20-004521 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200915 FILED AS OF DATE: 20200916 DATE AS OF CHANGE: 20200916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sklawer Andrew D CENTRAL INDEX KEY: 0001782334 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21088 FILM NUMBER: 201179064 MAIL ADDRESS: STREET 1: 5777 CENTRAL AVENUE, SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Brickell Biotech, Inc. CENTRAL INDEX KEY: 0000819050 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 930948554 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (720) 505-4755 MAIL ADDRESS: STREET 1: 5777 CENTRAL AVENUE STREET 2: SUITE 102 CITY: BOULDER STATE: CO ZIP: 80301 FORMER COMPANY: FORMER CONFORMED NAME: VICAL INC DATE OF NAME CHANGE: 19940211 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2020-09-15 0000819050 Brickell Biotech, Inc. BBI 0001782334 Sklawer Andrew D C/O BRICKELL BIOTECH, INC. 5777 CENTRAL AVENUE, SUITE 102 BOULDER CO 80301 0 1 0 0 COO and Secretary Stock Option (right to buy) .80 2020-09-15 4 A 0 450000 0 A 2030-09-15 Common Stock 450000 450000 D The stock options will vest 25% on September 15, 2021, and the remainder will vest in equal monthly installments over the following three years. /s/ Christine G. Long, Attorney-in-Fact for Andrew Sklawer (power of attorney previously filed) 2020-09-16